← Back
Data updated: Mar 10, 2026
Bayer
OncologyCardiovascularOphthalmology
Bayer is a major pharmaceutical company focused on Oncology, Cardiovascular, Ophthalmology. Key products include GADAVIST.
1949
Since
113
Drugs
-
Trials
33
Approved (2yr)
Key Drugs
GADAVIST
gadobutrol
6 indications · 2011
VITRAKVI
larotrectinib sulfate
TRKA 4 indications · 2018
KERENDIA
finerenone
Mineralocorticoid Receptor 4 indications · 2021
STIVARGA
regorafenib
Abl 3 indications · 2012
XOFIGO
radium ra-223 dichloride
DNA 2 indications · 2013
Recent Activity
EOVIST 2026-02-13
Labeling
GADAVIST 2026-02-13
Labeling
STIVARGA 2026-02-03
Labeling
HYRNUO 2025-11-19
Type 1 - New Molecular Entity
ASTEPRO ALLERGY 2025-10-27
Labeling
LYNKUET 2025-10-24
Type 1 - New Molecular Entity
AVELOX 2025-07-11
Labeling
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER 2025-07-11
Labeling
KERENDIA 2025-07-11
Efficacy
NUBEQA 2025-06-03
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 54%
3 drugs Phase 3: 12 Phase 2: 20 Phase 1: 63
Cardiovascular 19%
2 drugs Phase 3: 5 Phase 2: 7 Phase 1: 15
Ophthalmology 11%
0 drugs Phase 3: 7 Phase 1: 6
Dermatology 9%
3 drugs Phase 3: 1 Phase 2: 1 Phase 1: 4
Metabolic 7%
1 drugs Phase 3: 2 Phase 2: 3 Phase 1: 2
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Cardiovascular, Oncology, Dermatology, Ophthalmology
B BRAUN specialty
Ophthalmology, Dermatology, Metabolic, Cardiovascular
Novartis big-pharma
Oncology, Cardiovascular, Ophthalmology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Oncology, Cardiovascular
Merck big-pharma
Oncology, Cardiovascular, Metabolic
Active (41)
HYRNUO LYNKUET KERENDIA ASTEPRO ALLERGY CHILDREN'S ASTEPRO ALLERGY LAMPIT NUBEQA VITRAKVI KYLEENA ALEVE PM ADEMPAS XOFIGO SKYLA STIVARGA GADAVIST SAFYRAL BEYAZ NATAZIA EOVIST CHILDREN'S CLARITIN YAZ NEXAVAR ANGELIQ CLIMARA PRO ULTRAVIST (PHARMACY BULK) LOTRIMIN ULTRA YASMIN MIRENA AVELOX MIRALAX CLARITIN REDITABS CLARITIN HIVES RELIEF REDITAB CLARITIN-D 24 HOUR ULTRAVIST 300 ULTRAVIST 370 CLIMARA MENOSTAR CLARITIN-D ALEVE BETASERON CLARITIN
Discontinued (72)
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER CLARITIN HIVES RELIEF CIPRO BILTRICIDE ALIQOPA ALEVE-D SINUS & COLD ULTRAVIST 150 ULTRAVIST 300 IN PLASTIC CONTAINER ULTRAVIST 240 STAXYN LEVITRA CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER CIPRO XR MAGNEVIST CHLOR-TRIMETON PRECOSE GYNE-LOTRIMIN GYNE-LOTRIMIN 3 TRASYLOL RID MOUSSE NIMOTOP MYCELEX CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER GYNE-LOTRIMIN 3 COMBINATION PACK LEVLITE BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN MYCELEX-7 OCUCLEAR BAYCOL QUINAGLUTE GYNE-LOTRIMIN COMBINATION PACK MEZLIN DTIC-DOME ADALAT TRIDESILON FEMSTAT 3 SHADE UVAGUARD ACTRON BILIVIST UROVIST SODIUM 300 MEASURIN 8-HOUR BAYER MYCELEX-7 COMBINATION PACK DOMEBORO UROVIST CYSTO PEDIATRIC UROVIST CYSTO ANGIOVIST 292 ANGIOVIST 370 ANGIOVIST 282 LITHANE
+22 more
Company Info
- First Approval
- 1949-09-15
- Latest
- 2026-02-13
- Applications
- 133
FDA Sponsor Names
BAYER PHARMSBAYER HEALTHCARE LLCBAYER HLTHCAREBAYER HEALTHCAREBAYER +1